Gaba Therapeutics
gabarx.com
Actively hiring
Health Care
Neurology & CNS Therapeutics
Biotechnology
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
Robin Hood Ventures
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Apr 7, 2022
New executive GABA Therapeutics Appoints Mario David Saltarelli M.D., Ph.D. as CEO and CMO · YahooFinance
Backed byfrom the funds' portfolios and accelerator catalogs
Robin Hood Ventures Similar startupsby what they do, their industry and backers
A biotech company dedicated to developing transformative medicines for people with neurodegenerative diseases using cutting-edge science…
Lario Therapeutics are developing first-in-class disease modifying treatments for severe neurological disorders. Precision Neuroscience…
Draupnir Bio is developing new innovative therapies for patients.
Augustine Therapeutics is developing selective, safe and efficacious HDAC6 inhibitors designed for treatment of neuromuscular…
About Recycling Food Packaging How We Work Our Products News Contact Despite our anxiety about plastic waste, we can't quit these…
We’re building a pipeline of next-generation therapeutics focused on broadening the treatment paradigm for migraine and other headache…
News
atai Life Sciences Company GABA Therapeutics Announces Positive Final Results from Phase 1 Single and Multiple Ascending Dose Trial of GRX-917
--Today, atai Life Sciences N.V., a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, and its subsidiary GABA Therapeutics, announced final positive results from a Phase 1 clinical trial of GRX-917 that
Read more
Report
GABA Therapeutics Appoints Mario David Saltarelli M.D., Ph.D. as CEO and CMO
NEWPORT BEACH, Calif., April 07, 2022 (GLOBE NEWSWIRE) -- GABA Therapeutics, Inc, (
Read more
Report